StockData
Prothena Corp Public Ltd Co logo

Prothena Corp Public Ltd Co (PRTA) stock

PRTANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3022% below fair value
$8.26+0.29 (+3.64%)

Close on Nov 17, 2026Market cap $424.04MP/E –Yield –

Prothena Corp Public market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Prothena Corp Public's market cap was $451.73M on Nov 11, 2026, against $578.67M a year earlier. Over the last 5 years it ranged from $247.07M to $3.63B, with a median of $1.20B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$451.73M-12.1%
2025Dec 31, 2025$514.08M-31.0%
2024Dec 31, 2024$745.25M-61.8%
2023Dec 29, 2023$1.95B-32.4%
2022Dec 30, 2022$2.89B+25.5%
2021Dec 31, 2021$2.30B+379.4%
2020Dec 31, 2020$479.46M-24.1%
2019Dec 31, 2019$631.56M+53.8%
2018Dec 31, 2018$410.60M-71.5%
2017Dec 29, 2017$1.44B-15.0%
2016Dec 30, 2016$1.69B-21.1%
2015Dec 31, 2015$2.15B+277.7%
2014Dec 31, 2014$568.44M+21.2%
2013Dec 31, 2013$468.85M+341.2%
2012Dec 31, 2012$106.26M–

More Prothena Corp Public figures

See a number that looks wrong?